What is Buhlmann Diagnostics?
BUHLMANN Diagnostics Corp is a specialized provider of in vitro diagnostic products, catering to diverse medical fields including gastroenterology, autoimmunity, and neuroimmunology. The company offers a comprehensive suite of assays and solutions, featuring innovative tools for calprotectin, elastase, and allergy diagnostics, designed to support both clinical and research laboratories. With a legacy spanning nearly 50 years, BUHLMANN Diagnostics is recognized for its commitment to quality, innovation, and exceptional customer support, serving a broad client base in clinical, discovery, and basic science research.
How much funding has Buhlmann Diagnostics raised?
Buhlmann Diagnostics has raised a total of $129K across 1 funding round:
Debt
$129K
Debt (2021): $129K with participation from PPP
What's next for Buhlmann Diagnostics?
The recent strategic investment, alongside the company's substantial total funding of $129K, positions BUHLMANN Diagnostics for continued expansion and innovation in the competitive diagnostics sector. This capital infusion is expected to fuel advancements in their product development pipeline, enhance market penetration, and potentially explore new therapeutic areas. The company's late-stage funding context suggests a focus on scaling operations and solidifying its market leadership.
See full Buhlmann Diagnostics company page
